This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Search for Related Content Social Bookmarking                         What's this?

Metformin: a practical guide to optimising outcomes

• Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006;49:1711-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• National Institute for health and Clinical Excellence. Clinical Guideline G. Type 2 diabetes: the management type 2 diabetes (update). NICE. London 2008. www.nice.org.uk (Accessed May 2008)
• UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bailey CJ, Turner RC Metformin. N Engl J Med 1996; 334:574-9.[Free Full Text]
• Wiernsperger NF 50 years later: is metformin a vascular drug with antidiabetic properties? Br J Diabetes Vasc Dis 2007;7:204-10.[Abstract/Free Full Text]
• Zhou G., Myers R., Li Y. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Glucophage. Summary of Product Characteristics, 2004.
• Glucophage SR Summary of Product Characteristics, 2006.
• Feher MD, Al-Mrayat M., Brake J., Leong KS Tolerability of prolonged release metformin (Glucophage SR) in individuals intolerant to standard metformin - results from four UK centres. Br J Diabetes Vasc Dis 2007;7:22A5-8.
• Krentz AJ, Bailey CJ Type 2 diabetes in practice (2nd edn). Royal Society of Medicine Press, London, 2005, 206pp.
• Holstein A., Stumvoll M. Contraindications can damage your health - is metformin a case in point? Diabetologia 2005;48:2454-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Douek IF, Allen SE, Ewings P. et al. Continuing metformin when starting insulin in patients with type 2 diabetes: a double-blind randomised placebo-controlled trial. Diabetic Med 2005; 22:634-40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Salpeter S., Greyber E., Pasternak G., Salpeter E. Risk of fatal and non-fatal lactic acidosis with metformin use in type 2 diabetes mellitus Cochrane Database Syst Rev CD002967.

The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 3, 153-156 (2008)
DOI: 10.1177/14746514080080030801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Search for Related Content Social Bookmarking                         What's this?